Access to medicines for diabetes treatment in Brazil: evaluation of “health has no price” program

BACKGROUND: In 2011, private pharmacies associated to the Brazilian Ministry of Health provided patients with two types of insulin (regular human insulin and isophane insulin or NPH) and three oral antidiabetic medications (5 mg glibenclamide and 500 and 850 mg metformin) free of charge. The aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo, João Leopoldo Oliveira, Pereira, Mariana Donato, de Cássia Bergamaschi, Cristiane, de Sá Del Fiol, Fernando, Lopes, Luciane Cruz, de Toledo, Maria Inês, Barberato-Filho, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862091/
https://www.ncbi.nlm.nih.gov/pubmed/27168767
http://dx.doi.org/10.1186/s13098-016-0150-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862091/
https://www.ncbi.nlm.nih.gov/pubmed/27168767
http://dx.doi.org/10.1186/s13098-016-0150-8

Ejemplares similares